OXBRYTA
Were you or a loved one prescribed OXBRYTA (voxelotor) for treating sickle cell disease and had harmful side effects?
If so, you may have a claim for compensation.
Why might you or a loved one be entitled to compensation?
The manufacturer of OXBRYTA recently pulled the drug off the market because recent data indicates OXBRYTA has dangerous side effects.
Dovel & Luner is investigating potential claims on behalf of individuals that took OXBRYTA and experienced serious and potentially life-threatening side effects.
What are the dangerous side effects of OXBRYTA?
In September 2024, Pfizer Inc. announced plans to voluntarily recall OXBRYTA for the treatment of sickle cell disease (SCD).
According to the FDA, based on the totality of data collected through post marketing clinical trials of OXBRYTA, Pfizer has determined the benefit of taking the medication does not outweigh the risks.
Severe side effects experienced by SCD patients that used OXBRYTA include vaso-occlusive crises (severe pain and swelling caused by blockages of blood and oxygen circulation), organ failure, stroke, and even fatality in some cases.
Read more from the FDA here.
What is OXBRYTA?
OXBRYTA is a prescription medicine used for the treatment of SCD in adults and children 4 years of age and older.
According to the manufacturer: “OXBRYTA works by increasing hemoglobin’s affinity for oxygen. OXBRYTA inhibits sickle hemoglobin polymerization and the resultant sickling and destruction of red blood cells leading to hemolysis and hemolytic anemia, which are primary pathologies faced by every single person living with SCD.”